Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 5 ( September-October, 2019 ) > List of Articles

Original Article

Impact of New International Association of Diabetes in Pregnancy Study Group Criteria for Diagnosis of Gestational Diabetes on Pregnancy Outcome at a Tertiary Care Hospital Setting in Southern India

Aaradhita Yadagiri, Vasudev Guddattu

Keywords : Gestational diabetes, Glucose tolerance test, Glycemic control, Pregnancy outcome, Prospective study

Citation Information : Yadagiri A, Guddattu V. Impact of New International Association of Diabetes in Pregnancy Study Group Criteria for Diagnosis of Gestational Diabetes on Pregnancy Outcome at a Tertiary Care Hospital Setting in Southern India. J South Asian Feder Obs Gynae 2019; 11 (5):283-287.

DOI: 10.5005/jp-journals-10006-1710

License: CC BY-NC 4.0

Published Online: 18-07-2020

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Aim: To find the correlation of maternal and perinatal outcome with a single abnormal oral glucose tolerance test (OGTT) value and with at least two abnormal values, in women with gestational diabetes diagnosed as per International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria. Materials and methods: This was a prospective observational study. Women diagnosed with gestational diabetes as per IADPSG criteria were divided into four groups with a single abnormal value (fasting/one hour/two hour) and at least two abnormal values. Pregnancy outcomes were compared between the groups using Chi-squared test. Results: Among 392 women with gestational diabetes, 146 (37.2%), 44 (11.2%), 50 (12.8%) had fasting value, 1-hour value and 2-hour value abnormal, respectively, and 152 (38.8%) had at least two values abnormal. Women with risk factors for gestational diabetes had at least two abnormal values followed by the fasting abnormal group. Requirement of oral hypoglycemics and/or insulin was in 42/152 (27.6%) and 14/152 (9.2%), respectively, in the groups with at least two values deranged, 34/146 (23.3%) and 6/146 (4.1%) in the fasting abnormal group, which are higher compared to other groups (p = 0.01). Recurrent urinary infection (28%) and polyhydramnios/macrosomia (38%) were significantly in the group with at least two abnormal values. Preterm labor/PROM was more with groups with fasting hyperglycemia (37%) and 2nd hour glucose abnormality (36%). Conclusion: Though more than two abnormal GTT values and fasting hyperglycemia were higher in high risk women who also required antiglycemic medications, the maternal and perinatal outcome was not specifically associated with any of the abnormal GTT value individually. Clinical significance: The study may have a role in decision-making regarding the screening and diagnostic strategies of gestational diabetes to be adopted in the Indian setting.


HTML PDF Share
  1. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2016;39(Suppl 1):S13–S22. DOI: 10.2337/dc16-S005.
  2. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep 2016;16(1):7. DOI: 10.1007/s11892-015-0699-x.
  3. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358(19):1991–2002. DOI: 10.1056/NEJMoa0707943.
  4. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1773–1779. DOI: 10.1016/S0140-6736(09)60731-5.
  5. Sullivan SD, Umans JG, Ratner R. Gestational diabetes: implications for cardiovascular health. Curr Diab Rep 2012;12(1):43–52. DOI: 10.1007/s11892-011-0238-3.
  6. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynaecol Obstet 2002;78(1):69–77. DOI: 10.1016/S0020-7292(02)00092-9.
  7. Arora GP, Thaman RG, Prasad RB, et al. Prevalence and risk factors of gestational diabetes in Punjab, North India: results from a population screening program. Eur J Endocrinol 2015;173(2):257–267. DOI: 10.1530/EJE-14-0428.
  8. Gopalakrishnan V, Singh R, Pradeep Y, et al. Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Postgrad Med 2015;61(3):155–158. DOI: 10.4103/0022-3859.159306.
  9. Kayal A, Anjana RM, Mohan V, Gestational diabetes-An update from India, 2013. Diabetes Voice 58, 2013. [Last accessed on 2015 Aug 15]. Available from: http://www.idf.org/gestational.diabetes.
  10. Agarwal MM, Dhatt GS, Shah SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010;33(9):2018–2020. DOI: 10.2337/dc10-0572.
  11. Jenum AK, Mørkrid K, Sletner L, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol 2012;166(2):317–324. DOI: 10.1530/EJE-11-0866.
  12. Lao TT, Ho LF, Chan BC. Maternal age and prevalence of gestational diabetes mellitus. Diabetes Care 2006;29(4):948–949. DOI: 10.2337/diacare.29.04.06.dc05-2568.
  13. Kuo CH, Chen SC, Fang CT, et al. Screening gestational diabetes mellitus: the role of maternal age. PLoS One 2017;12(3):e0173049. DOI: 10.1371/journal.pone.0173049.
  14. Al-rowaily MA, Abolfotouh MA. Predictors of gestational diabetes mellitus in a high-parity community in Saudi Arabia. East Mediterr Health J 2010;16(6):636–641. DOI: 10.26719/2010.16.6.636.
  15. Seghieri G, De Bellis A, Anichini R, et al. Does parity increase insulin resistance during pregnancy? Diabet Med 2005;22(11):1574–1580. DOI: 10.1111/j.1464-5491.2005.01693.x.
  16. Bhat M, KN R, Sarma SP, et al. Determinants of gestational diabetes mellitus: a case control study in a district tertiary care hospital in south India. Int J Diabetes Dev Ctries 2010;30(2):91–96. DOI: 10.4103/0973-3930.62599.
  17. Ashrafi M, Sheikhan F, Arabipoor A, et al. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS). Eur J Obstet Gynecol Reprod Biol 2014;181:195–199. DOI: 10.1016/j.ejogrb.2014.07.043.
  18. Teh WT, Teede HJ, Paul E, et al. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol 2011;51(1):26–30. DOI: 10.1111/j.1479-828X.2011.01292.x.
  19. Coustan DR, Lowe LP, Metzger BE, et al. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 2010;202(6):654.e1–654.e6. DOI: 10.1016/j.ajog.2010.04.006.
  20. Sacks DA, Hadden DR, Maresh M, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35(3):526–528. DOI: 10.2337/dc11-1641.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.